Cardiac remodelling in secondary tricuspid regurgitation: Should we look beyond the tricuspid annulus diameter?


Journal

Archives of cardiovascular diseases
ISSN: 1875-2128
Titre abrégé: Arch Cardiovasc Dis
Pays: Netherlands
ID NLM: 101465655

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 21 06 2020
revised: 20 09 2020
accepted: 17 11 2020
pubmed: 16 1 2021
medline: 2 6 2021
entrez: 15 1 2021
Statut: ppublish

Résumé

A better understanding of the mechanism of tricuspid regurgitation severity would help to improve the management of this disease. We sought to characterize the determinants of isolated secondary tricuspid regurgitation severity in patients with preserved left ventricular ejection fraction. This was a prospective observational multicentre study. Patients with severe tricuspid regurgitation were asked to participate in a registry that required a control echocardiogram after optimization of medical treatment and a follow-up. Patients had to have at least mild secondary tricuspid regurgitation when clinically stable, and were classified according to five grades of tricuspid regurgitation severity, based on effective regurgitant orifice area. One hundred patients with tricuspid regurgitation (12 mild, 31 moderate, 18 severe, 17 massive and 22 torrential) were enrolled. Right atrial indexed volume and tethering area were statistically associated with the degree of tricuspid regurgitation (P<0.001 and P=0.005, respectively). When the tricuspid annular diameter was≥50mm, the probability of having severe tricuspid regurgitation or a higher grade was>70%. For an increase of 10mL/m For tricuspid regurgitation to be severe or torrential, both right atrial dilatation and leaflet tethering are needed. Interestingly, right cavities dilated progressively with tricuspid regurgitation severity, without joint degradation of right ventricular systolic function variables.

Sections du résumé

BACKGROUND BACKGROUND
A better understanding of the mechanism of tricuspid regurgitation severity would help to improve the management of this disease.
AIM OBJECTIVE
We sought to characterize the determinants of isolated secondary tricuspid regurgitation severity in patients with preserved left ventricular ejection fraction.
METHODS METHODS
This was a prospective observational multicentre study. Patients with severe tricuspid regurgitation were asked to participate in a registry that required a control echocardiogram after optimization of medical treatment and a follow-up. Patients had to have at least mild secondary tricuspid regurgitation when clinically stable, and were classified according to five grades of tricuspid regurgitation severity, based on effective regurgitant orifice area.
RESULTS RESULTS
One hundred patients with tricuspid regurgitation (12 mild, 31 moderate, 18 severe, 17 massive and 22 torrential) were enrolled. Right atrial indexed volume and tethering area were statistically associated with the degree of tricuspid regurgitation (P<0.001 and P=0.005, respectively). When the tricuspid annular diameter was≥50mm, the probability of having severe tricuspid regurgitation or a higher grade was>70%. For an increase of 10mL/m
CONCLUSIONS CONCLUSIONS
For tricuspid regurgitation to be severe or torrential, both right atrial dilatation and leaflet tethering are needed. Interestingly, right cavities dilated progressively with tricuspid regurgitation severity, without joint degradation of right ventricular systolic function variables.

Identifiants

pubmed: 33446476
pii: S1875-2136(20)30263-1
doi: 10.1016/j.acvd.2020.11.002
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

277-286

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

Anne Guérin (A)

Université de Rennes 1, 35043 Rennes, France; Department of Cardiology, CHU Rennes, 35000 Rennes, France.

Elsa Vabret (E)

Université de Rennes 1, 35043 Rennes, France.

Julien Dreyfus (J)

Department of Cardiology, Centre Cardiologique du Nord, 93000 Saint-Denis, France.

Yoan Lavie-Badie (Y)

Department of Cardiology, Rangueil University Hospital, 31000 Toulouse, France.

Catherine Sportouch (C)

Department of Cardiology, Clinique du Millénaire, 34000 Montpellier, France.

Jean-Christophe Eicher (JC)

Department of Cardiology, CHU François-Mitterrand, 21000 Dijon, France.

Sylvestre Maréchaux (S)

Groupement des hôpitaux de l'Institut Catholique de Lille, Faculté de Médecine et Maïeutique, 59000 Lille, France.

Thierry Le Tourneau (T)

L'institut du Thorax, CHU Nantes, 44000 Nantes, France.

Erwan Donal (E)

Université de Rennes 1, 35043 Rennes, France; Department of Cardiology, CHU Rennes, 35000 Rennes, France. Electronic address: erwan.donal@chu-rennes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH